Sildenafil pessaries leverage targeted vaginal administration to deliver a high concentration of the phosphodiesterase-5 inhibitor directly to the pelvic vasculature, optimizing local tissue bioavailability. By facilitating potent nitric oxide-mediated vasodilation, this formulation significantly enhances endometrial blood flow and uterine perfusion, which are critical for improving clinical outcomes in patients requiring localized vascular support. This specialized delivery route provides a distinct therapeutic advantage by achieving maximal efficacy at the site of action while minimizing the systemic absorption and adverse effects typically associated with oral administration.

Reviews
There are no reviews yet.